初次全膝关节置换术后诊断为COVID-19的翻修患者并发症发生率
基于2018至2021年8,022例翻修全膝关节置换(rTKA)患者数据,60例术后90天内诊断COVID-19者与600例无COVID-19的rTKA患者及600例未行rTKA的COVID-19阳性患者进行1:10倾向评分匹配,多因素logistic回归比较90天并发症,发现rTKA/COVID阳性组肺炎、肺栓塞、深静脉血栓和90天再入院率显著升高。
要点
- rTKA术后90天内诊断COVID-19者肺炎风险显著高于无COVID-19的rTKA患者(OR=6.1,P<.001)
- rTKA术后COVID-19组肺栓塞和深静脉血栓风险显著升高(OR均为32.4,P<.001)
- rTKA术后COVID-19组90天再入院率显著升高(OR=2.1,P=.02)
核心结论
- 翻修全膝关节置换术后诊断COVID-19的患者血栓栓塞事件、肺炎和90天再入院率增加。
- 降低风险的措施提示应延长rTKA术后诊断COVID-19患者的预防性抗凝时间。
研究设计与样本
- 利用大型国家数据库查询2018至2021年间8,022例接受rTKA的患者。
- 其中60例在术后90天内诊断COVID-19(rTKA/COVID阳性),以1:10倾向评分匹配至600例术后90天无COVID-19诊断的rTKA患者(rTKA/COVID阴性)和600例未行rTKA的COVID-19阳性患者。
- 采用多因素logistic回归控制潜在混杂因素,比较组间90天术后并发症。
主要发现
- 与rTKA/COVID阴性组相比,rTKA/COVID阳性组肺炎(OR=6.1,P<.001)、肺栓塞(OR=32.4,P<.001)、深静脉血栓(OR=32.4,P<.001)和90天再入院(OR=2.1,P=.02)发生率显著更高。
- 与未行rTKA的COVID-19阳性患者相比,rTKA/COVID阳性组肺炎(OR=4.3,P=.001)、肺栓塞(OR=36.8,P<.001)和深静脉血栓(OR=36.8,P<.001)发生率显著更高。
临床怎么用
- 作者提出降低风险的措施提示应延长rTKA术后诊断COVID-19患者的预防性抗凝时间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic introduced a new set of challenges for the arthroplasty community, including the management of patients diagnosed with COVID-19 following revision total knee arthroplasty (rTKA) and its potential impact on postoperative recovery. This study sought to characterize the risks of postoperative COVID-19 infection among rTKA patients. METHODS: A large national database was utilized to query 8,022 total patients who underwent rTKA between 2018 and 2021, of which 60 had a COVID diagnosis within 90 days after surgery (rTKA/COVID positive). These patients were 1:10 propensity-score matched to 600 rTKA patients who did not have a 90-day postoperative COVID diagnosis (rTKA/COVID negative) and 600 COVID positive patients who did not undergo rTKA. Controlling for potential confounders, multivariate logistic regressions were utilized to compare 90-day postoperative complications between groups. RESULTS: Compared to rTKA/COVID negativepatients, the rTKA/COVID positive cohort had significantly higher rates of pneumonia (odds ratio [OR] = 6.1, P < .001), pulmonary embolism (PE) (OR = 32.4, P < .001), deep venous thrombosis (DVT) (OR = 32.4, P < .001), and 90-day readmissions (OR = 2.1, P = .02). Similarly, the rTKA/COVID positive cohort had significantly higher rates of pneumonia (OR = 4.3, P = .001), PE (OR = 36.8, P < .001), and DVT (OR = 36.8, P < .001) compared to COVID positive patients who did not undergo rTKA. CONCLUSIONS: Revision total knee arthroplasty patients diagnosed with COVID-19 postoperatively had increased rates of thromboembolic events, pneumoniae, and 90-day readmissions. Risk mitigation efforts would suggest extending the prophylactic anticoagulation period for rTKA patients diagnosed with postoperative COVID-19.
引用
- Heo KY, Bonsu JM, Muffly BT, et al. Complications Rates Among Revision Total Knee Arthroplasty Patients Diagnosed With COVID-19 Postoperatively. J Arthroplasty. 2023. PMID: 37757979. doi:10.1016/j.arth.2023.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。